These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 32469805)
21. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Clayton WJ; Lipton M; Elford J; Rustin M; Sherr L Br J Dermatol; 2005 May; 152(5):986-92. PubMed ID: 15888157 [TBL] [Abstract][Full Text] [Related]
22. Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial. Stefanaki C; Bacopoulou F; Livadas S; Kandaraki A; Karachalios A; Chrousos GP; Diamanti-Kandarakis E Stress; 2015 Jan; 18(1):57-66. PubMed ID: 25287137 [TBL] [Abstract][Full Text] [Related]
23. Impact of polycystic ovary syndrome on eating behavior, depression and health related quality of life: A cross-sectional study in Riyadh. Asdaq SMB; Jomah S; Hasan R; Al-Baroudi D; Alharbi M; Alsubaie S; Buhamad MH; Alyahya B; Al-Yamani MJ Saudi J Biol Sci; 2020 Dec; 27(12):3342-3347. PubMed ID: 33304140 [TBL] [Abstract][Full Text] [Related]
24. A study on clinical and sonographic features in obese and nonobese patients with polycystic ovary syndrome. Siddiqui IA; Tamimi W; Tamim H; Aleisa N; Adham M Arch Gynecol Obstet; 2010 Mar; 281(3):467-71. PubMed ID: 19462174 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An-Najah national university-Palestine. Musmar S; Afaneh A; Mo'alla H Reprod Biol Endocrinol; 2013 May; 11():47. PubMed ID: 23688000 [TBL] [Abstract][Full Text] [Related]
26. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763 [TBL] [Abstract][Full Text] [Related]
28. The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966. West S; Vähäsarja M; Bloigu A; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Corbett S; Vääräsmäki M; Morin-Papunen L Hum Reprod; 2014 Mar; 29(3):628-33. PubMed ID: 24324025 [TBL] [Abstract][Full Text] [Related]
29. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559 [TBL] [Abstract][Full Text] [Related]
30. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776 [TBL] [Abstract][Full Text] [Related]
31. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Cinar N; Kizilarslanoglu MC; Harmanci A; Aksoy DY; Bozdag G; Demir B; Yildiz BO Hum Reprod; 2011 Dec; 26(12):3339-45. PubMed ID: 21984577 [TBL] [Abstract][Full Text] [Related]
32. A genetic risk score is associated with polycystic ovary syndrome-related traits. Lee H; Oh JY; Sung YA; Chung HW Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of affective temperament and anxiety-depression levels of patients with polycystic ovary syndrome. Asik M; Altinbas K; Eroglu M; Karaahmet E; Erbag G; Ertekin H; Sen H J Affect Disord; 2015 Oct; 185():214-8. PubMed ID: 26241866 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up. Hudecova M; Holte J; Olovsson M; Larsson A; Berne C; Sundstrom-Poromaa I Fertil Steril; 2011 Nov; 96(5):1271-4. PubMed ID: 21872228 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Taponen S; Ahonkallio S; Martikainen H; Koivunen R; Ruokonen A; Sovio U; Hartikainen AL; Pouta A; Laitinen J; King V; Franks S; McCarthy MI; Järvelin MR Hum Reprod; 2004 May; 19(5):1083-8. PubMed ID: 15044401 [TBL] [Abstract][Full Text] [Related]
36. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome. Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780 [TBL] [Abstract][Full Text] [Related]
37. The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis. Wang Y; Ni Z; Li K Gynecol Endocrinol; 2021 Dec; 37(12):1072-1078. PubMed ID: 34165386 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus. Kelestimur F; Unluhizarci K; Baybuga H; Atmaca H; Bayram F; Sahin Y Fertil Steril; 2006 Aug; 86(2):405-10. PubMed ID: 16762349 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort. Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903 [TBL] [Abstract][Full Text] [Related]
40. Psychiatric comorbidities and adverse childhood experiences in women with self-reported polycystic ovary syndrome: An Australian population-based study. Tay CT; Teede HJ; Loxton D; Kulkarni J; Joham AE Psychoneuroendocrinology; 2020 Jun; 116():104678. PubMed ID: 32361187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]